Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
Matinas BioPharma Holdings reports 2019 executive compensation
By ExecPay News
Published: October 1, 2020
Matinas BioPharma Holdings reported fiscal year 2019 executive compensation information on October 1, 2020.
In 2019, five executives at Matinas BioPharma Holdings received on average a compensation package of $717K, a 44% increase compared to previous year.
Average pay of disclosed executives at Matinas BioPharma Holdings
Jerome D. Jabbour, Chief Executive Officer, received $1.3M in total, which increased by 6% compared to 2018. 51% of Jabbour's compensation, or $680K, was in option awards. Jabbour also received $200K in bonus and $445K in salary.
James J. Ferguson, Chief Medical Officer, received a compensation package of $752K. 43% of the compensation package, or $320K, was in option awards.
Theresa Matkovits, Chief Development Officer, earned $698K in 2019, a 128% increase compared to previous year.
Keith A. Kucinski, Chief Financial Officer, received $627K in 2019.
Roelof Rongen, Chief Executive Officer, earned $183K in 2019, a 54% decrease compared to previous year.
Related executives
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
Keith Kucinski
Matinas BioPharma Holdings
Chief Financial Officer
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Theresa Matkovits
Matinas BioPharma Holdings
Chief Development Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
You may also like
Source: SEC filing on October 1, 2020.